NADYA MENDEZ: Open Payments
NPI 1871045112 · MISSION, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$707 in 25 payments from 10 companies in 2025. Trend: 2023 $1,032 · 2024 $995 · 2025 $707
Food & beverage: $707
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $185 |
| Novo Nordisk Inc | 8 | $183 |
| AstraZeneca Pharmaceuticals LP | 3 | $178 |
| Exact Sciences Corporation | 3 | $46 |
| PFIZER INC. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Abbott Laboratories | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: Ozempic, BREZTRI, ZEPBOUND, Cologuard Collection Kit, FARXIGA, JARDIANCE, MOUNJARO, PAXLOVID.
Industry payments across TX — which companies pay providers there.
